What is COPD?
COPD is a long-term lung condition in which airflow is persistently limited and does not fully reverse. It combines airway inflammation and narrowing with damage to the air sacs (emphysema), causing progressive breathlessness, chronic cough, and sputum. Diagnosis requires spirometry showing a post-bronchodilator FEV1/FVC ratio below 0.70. Smoking is the leading cause.
Key takeaways
- Diagnosis requires spirometry — symptoms alone are not enough, and COPD is both under- and over-diagnosed without it.
- Stopping smoking is the only intervention proven to slow the decline in lung function.
- Pulmonary rehabilitation improves breathlessness and quality of life as much as many medications.
- Exacerbations accelerate decline, so preventing them is a central treatment goal.
- Vaccination against influenza, pneumococcus, COVID-19, and RSV is standard preventive care.
Overview
Chronic obstructive pulmonary disease is a leading cause of death worldwide and is characterised by airflow limitation that does not fully reverse. Two processes overlap in most people. Chronic bronchitis involves inflammation and narrowing of the airways with excess mucus, producing cough and sputum. Emphysema involves destruction of the walls of the alveoli, the tiny air sacs where gas exchange occurs, which reduces the surface area available for oxygen and causes the lungs to lose their elastic recoil so air becomes trapped.
Long-term tobacco smoking causes the majority of cases in high-income countries, but exposure to biomass fuel smoke, occupational dusts, and air pollution are major contributors globally, and a minority of cases relate to inherited alpha-1 antitrypsin deficiency. COPD is progressive but far from untreatable: stopping smoking, pulmonary rehabilitation, appropriate inhaled therapy, vaccination, and prevention of exacerbations all meaningfully change the trajectory and how people feel day to day.
What COPD is
COPD is confirmed by spirometry showing a post-bronchodilator FEV1/FVC ratio below 0.70 — meaning that less than 70% of the air a person can exhale comes out in the first second. Severity of airflow limitation is then graded by FEV1 as a percentage of predicted, though symptoms and exacerbation history matter at least as much for treatment decisions.
An exacerbation is an acute worsening of breathlessness, cough, or sputum beyond normal day-to-day variation, usually triggered by a viral or bacterial infection or by air pollution. Exacerbations matter enormously: each one is associated with a step down in lung function and quality of life that is often not fully recovered, and frequent exacerbations predict worse outcomes.
Common symptoms
Symptoms develop gradually and are frequently attributed to ageing or being unfit until they are well established.
- Breathlessness, initially only with exertion and later with everyday activity
- Chronic cough, often producing sputum, especially in the morning
- Wheeze and chest tightness
- Frequent chest infections that take a long time to clear
- Reduced exercise tolerance developing over years
- Fatigue
- A sense of not being able to take a full breath in, from air trapping
Less common symptoms
- Unintentional weight loss and muscle wasting in advanced disease
- Ankle swelling from strain on the right side of the heart
- Morning headache from carbon dioxide retention
- Blue-tinged lips or fingers
- Anxiety and depression, which are common and under-recognised
Risk factors
- Tobacco smoking — the dominant cause, with risk rising with pack-years
- Secondhand smoke exposure
- Occupational dust, vapour, and fume exposure — mining, construction, farming, and manufacturing
- Indoor biomass fuel smoke from cooking or heating — a major cause globally, especially in women
- Outdoor air pollution, particularly fine particulate matter
- Alpha-1 antitrypsin deficiency — an inherited cause, suspected with early-onset or family-clustered disease
- Poor lung growth in childhood from prematurity, severe infections, or early smoke exposure
- Long-standing poorly controlled asthma — can lead to fixed airflow limitation
- Age — symptoms usually appear after 40 because damage accumulates over decades
Causes
COPD develops when inhaled particles and gases cause chronic inflammation in the airways and lung tissue. In susceptible people this inflammation persists and becomes self-sustaining even after exposure stops. Enzymes released by inflammatory cells break down elastin in the alveolar walls faster than it can be repaired, producing emphysema; airway walls thicken and fill with mucus, producing obstruction. Oxidative stress from smoke amplifies both processes.
Not everyone who smokes develops COPD, which points to genetic susceptibility. Alpha-1 antitrypsin deficiency is the clearest example: without this protective protein, enzyme activity goes unchecked and emphysema can develop early, sometimes in people who have never smoked. Testing is recommended at least once for anyone diagnosed with COPD.
How it is diagnosed
Spirometry is required to make the diagnosis; other tests characterise severity and exclude alternatives.
| Test or assessment | What it looks at |
|---|---|
| Post-bronchodilator spirometry | The diagnostic test. An FEV1/FVC ratio below 0.70 after a bronchodilator confirms persistent airflow limitation, and FEV1 percent predicted grades severity. |
| Symptom and exacerbation assessment | Tools such as the CAT questionnaire and the mMRC breathlessness scale, together with exacerbation history, guide treatment more than lung function alone. |
| Chest X-ray or CT | Excludes other causes such as heart failure, lung cancer, and bronchiectasis, and CT can define emphysema pattern and screen for lung cancer in eligible smokers. |
| Alpha-1 antitrypsin testing | Recommended at least once for everyone diagnosed with COPD, particularly with early onset, a family history, or limited smoking exposure. |
| Pulse oximetry and arterial blood gases | Assess oxygen levels and identify people who may benefit from long-term oxygen therapy or who are retaining carbon dioxide. |
| Blood eosinophil count | Helps predict who is likely to benefit from adding an inhaled corticosteroid to their regimen. |
Treatment overview
Treatment reduces symptoms, improves exercise capacity, and prevents exacerbations. The categories below describe available approaches; specific inhalers, devices, and dosing are set by your clinician.
Smoking cessation
The only intervention proven to slow the decline in lung function. Combining behavioural support with pharmacotherapy substantially improves success rates.
Pulmonary rehabilitation
A structured program of supervised exercise, education, and support. Its effect on breathlessness and quality of life is comparable to major medications, and it is significantly underused.
Long-acting bronchodilators
LAMA and LABA inhalers, alone or in combination, are the foundation of maintenance therapy and improve airflow and symptoms.
Inhaled corticosteroid combinations
Added for people with frequent exacerbations or higher blood eosinophil counts, balanced against a modest increase in pneumonia risk.
Exacerbation prevention and management
Action plans, prompt treatment with bronchodilators, and corticosteroids or antibiotics when indicated; some people benefit from preventive therapies such as roflumilast or long-term azithromycin.
Vaccination
Influenza, pneumococcal, COVID-19, RSV, and pertussis-containing vaccines as recommended, since infection is the main trigger of exacerbations.
Oxygen and advanced therapies
Long-term oxygen therapy for sustained low oxygen levels, non-invasive ventilation for chronic carbon dioxide retention, and lung volume reduction or transplantation in selected cases.
Lifestyle considerations
- Stop smoking — nothing else changes the course of COPD as much, and it helps at any stage.
- Ask for a pulmonary rehabilitation referral; the benefit is large and often surprises people who expected to be told to rest.
- Keep moving daily, even when breathless — deconditioning worsens breathlessness in a self-reinforcing spiral.
- Learn pursed-lip breathing and paced activity techniques for managing breathlessness.
- Stay current with recommended vaccinations.
- Eat well and maintain weight; both being underweight and being overweight worsen outcomes.
- Have a written action plan and know when to start rescue treatment or seek help.
- Avoid indoor and outdoor air pollution where you can, and check technique on every inhaler you use.
Prevention
- Never start smoking, and stop as early as possible if you do — most COPD is preventable.
- Avoid secondhand smoke.
- Use protective equipment and follow exposure controls for occupational dusts, fumes, and vapours.
- Improve indoor air quality, including ventilation for cooking and heating with solid fuels.
- Treat childhood respiratory infections and asthma well, since early lung growth affects lifelong function.
- Get tested for alpha-1 antitrypsin deficiency if COPD is diagnosed young or runs in the family.
- Stay vaccinated to reduce exacerbations that accelerate decline.
Warning signs and when to get help
Signs that need emergency care
If you believe you are experiencing a medical emergency, call emergency services immediately (911 in the United States).
- Severe breathlessness at rest or inability to speak in full sentences — call emergency services
- Blue or grey lips, tongue, or fingertips
- Confusion, marked drowsiness, or a drop in alertness — may indicate carbon dioxide retention
- Chest pain with breathlessness, or coughing up significant blood
- Sudden severe breathlessness with sharp chest pain — possible collapsed lung or pulmonary embolism
Signs that warrant a prompt appointment
These are not emergencies, but they are worth a call to your clinician rather than a wait-and-see.
- Increased breathlessness, cough, or sputum beyond your usual variation
- Sputum changing colour, thickness, or volume
- Needing your reliever inhaler far more often than usual
- New ankle swelling
- Fever or symptoms of a chest infection
- Unintentional weight loss or worsening fatigue
Questions to ask a healthcare professional
Take these to your next appointment — or build an agenda with the Appointment Prep tool.
- What did my spirometry show, and how severe is my airflow limitation?
- Have I been tested for alpha-1 antitrypsin deficiency?
- Can I be referred to pulmonary rehabilitation?
- Which inhalers am I on, what does each do, and can you check my technique?
- What should I do at the first sign of an exacerbation?
- Do I need a rescue pack at home, and when should I use it?
- Am I eligible for lung cancer screening given my smoking history?
- Should my oxygen levels be assessed?
Frequently asked questions
Is it too late to quit smoking if I already have COPD?
No. Stopping smoking is the only intervention shown to slow the ongoing decline in lung function, and it reduces exacerbations, symptoms, and cardiovascular risk at any stage. Lung function already lost does not return, but the rate of further loss slows toward normal ageing.
What is the difference between asthma and COPD?
Asthma typically starts younger, varies markedly over time, and reverses substantially with a bronchodilator. COPD usually starts after 40 in people with significant exposure history, is persistent, and does not fully reverse. Some people have features of both, sometimes called asthma-COPD overlap.
What is pulmonary rehabilitation and does it really help?
It is a structured multi-week program combining supervised exercise, breathing techniques, education, and support. It improves breathlessness, exercise capacity, and quality of life as much as many drug treatments, and reduces hospital readmission after exacerbations. It is one of the most underused effective treatments in COPD.
Will I need oxygen?
Only some people do. Long-term oxygen therapy is prescribed when blood oxygen is persistently low, measured formally rather than judged by symptoms, and it improves survival in that group. Breathlessness alone without low oxygen is not treated with oxygen.
Does exercise make COPD worse?
No — avoiding exercise does. Breathlessness leads to reduced activity, which causes deconditioning and more breathlessness at lower workloads. Structured exercise, ideally through pulmonary rehabilitation, breaks that cycle safely.
Sources
- NHLBI — COPD — NIH overview of diagnosis, treatment, and living with COPD
- CDC — COPD — US prevalence, risk factors, and prevention
- American Lung Association — Patient education, rehabilitation, and quit-smoking support
- MedlinePlus — COPD — Consumer summary and related tests
Health Captain links to primary public-health and clinical sources so you can read the original material yourself. See our sources policy.